Terms: = Head and neck cancer AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321 AND Treatment
9 results:
1. Serum lactate dehydrogenase in the prognostic assessment of patients with oral squamous cell carcinoma.
Sudha J; Julius A; Jimson S; Padmavathy K
Indian J Dent Res; 2022; 33(2):164-168. PubMed ID: 36254953
[TBL] [Abstract] [Full Text] [Related]
2. [Analysis of clinical characteristics of patients with hyperthyroidism combined with liver injury].
Sheng QJ; Ding Y; Zhang C; Han C; Li YW; Fan YX; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):967-971. PubMed ID: 34814390
[No Abstract] [Full Text] [Related]
3. Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal cancer: National Population-based Cohort Study.
Kamarajah SK; Phillips AW; Hanna GB; Low D; Markar SR
Ann Surg; 2022 Mar; 275(3):526-533. PubMed ID: 32865948
[TBL] [Abstract] [Full Text] [Related]
4. [Endoscopic removal of middle ear haemangioma and review of the literature].
Hirschberg A; Pozsgay E; Erős M; Liktor B
Orv Hetil; 2019 Oct; 160(41):1639-1643. PubMed ID: 31587577
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of Saliva Gene Expression during head and neck cancer Radiotherapy: A Pilot Study.
Lacombe J; Brooks C; Hu C; Menashi E; Korn R; Yang F; Zenhausern F
Radiat Res; 2017 Jul; 188(1):75-81. PubMed ID: 28504589
[TBL] [Abstract] [Full Text] [Related]
6. Mortality risk in patients with chronic rhinosinusitis and its association to asthma.
Alt JA; Thomas AJ; Curtin K; Wong J; Rudmik L; Orlandi RR
Int Forum Allergy Rhinol; 2017 Jun; 7(6):591-599. PubMed ID: 28272838
[TBL] [Abstract] [Full Text] [Related]
7. Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
Peng H; Chen L; Li WF; Guo R; Mao YP; Zhang Y; Guo Y; Sun Y; Ma J
Cancer; 2017 May; 123(9):1643-1652. PubMed ID: 28001301
[TBL] [Abstract] [Full Text] [Related]
8. Degree of tumor shrinkage following neoadjuvant chemoradiotherapy: a potential predictor for complete pathological response in esophageal cancer?
Voncken FE; Jiang H; Kim J; Guindi M; Brierley J; Knox J; Liu G; Horgan AM; Lister J; Darling G; Metser U; Wong RK
Dis Esophagus; 2014 Aug; 27(6):552-9. PubMed ID: 23121504
[TBL] [Abstract] [Full Text] [Related]
9. Curative radiotherapy with high-dose-rate brachytherapy boost for localized esophageal carcinoma: dose-effect relationship of brachytherapy with the balloon type applicator system.
Yorozu A; Dokiya T; Oki Y; Suzuki T
Radiother Oncol; 1999 May; 51(2):133-9. PubMed ID: 10435804
[TBL] [Abstract] [Full Text] [Related]
